{
    "2019-09-08": [
        [
            {
                "time": "2023-09-08",
                "original_text": "病理免疫组化为被市场遗忘的“小化学发光”【西南医药|0908周报】",
                "features": {
                    "keywords": [
                        "病理免疫组化",
                        "小化学发光",
                        "市场遗忘",
                        "西南医药",
                        "周报"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-09-15",
                "original_text": "引来高瓴和淡马锡 千亿市值的爱尔眼科还能否保持高增长？",
                "features": {
                    "keywords": [
                        "高瓴",
                        "淡马锡",
                        "爱尔眼科",
                        "千亿市值",
                        "高增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "眼科"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}